| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | CARM1 BCL9L NCOA3 NCOA6 PRPF6 ZMIZ1 BCL9 NKX2-1 CREBBP MAML3 | 1.76e-09 | 303 | 47 | 10 | GO:0003713 |
| GeneOntologyMolecularFunction | transcription coregulator activity | CARM1 BCL9L NCOA3 NCOA6 PRPF6 ZMIZ1 BCL9 NKX2-1 CREBBP MAML3 | 5.84e-07 | 562 | 47 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription factor binding | NFYA CARM1 NCOA3 NCOA6 CHD6 PRPF6 FOXA2 NKX2-1 CREBBP MEIS2 ARNT2 | 1.03e-06 | 753 | 47 | 11 | GO:0008134 |
| GeneOntologyMolecularFunction | molecular adaptor activity | DAB2 CARM1 BCL9L NCOA3 NCOA6 IRS1 PRPF6 ZMIZ1 SGTB BCL9 NKX2-1 CREBBP MAML3 | 9.82e-06 | 1356 | 47 | 13 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | DAB2 CARM1 BCL9L NCOA3 NCOA6 IRS1 PRPF6 ZMIZ1 BCL9 NKX2-1 CREBBP MAML3 | 1.09e-05 | 1160 | 47 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.27e-05 | 61 | 47 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.58e-05 | 21 | 47 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | SMAD binding | 4.97e-05 | 86 | 47 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.98e-05 | 37 | 47 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.96e-04 | 739 | 47 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 3.12e-04 | 560 | 47 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 3.27e-04 | 140 | 47 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 3.33e-04 | 566 | 47 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.94e-04 | 582 | 47 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.16e-04 | 417 | 47 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | clathrin binding | 4.40e-04 | 63 | 47 | 3 | GO:0030276 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | NFYA ADNP2 ONECUT2 NCOA3 ZFHX4 FOXA2 NKX2-1 MEIS2 ARNT2 ZBTB8B | 1.40e-03 | 1412 | 47 | 10 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | NFYA ONECUT2 NCOA3 CHD7 ZFHX4 FOXA2 NKX2-1 CREBBP MEIS2 ARNT2 | 1.80e-03 | 1459 | 47 | 10 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.73e-03 | 33 | 47 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.83e-03 | 120 | 47 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.90e-03 | 34 | 47 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.32e-03 | 262 | 47 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.32e-03 | 127 | 47 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 3.80e-03 | 39 | 47 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.12e-03 | 875 | 47 | 7 | GO:0019904 | |
| GeneOntologyMolecularFunction | helicase activity | 6.11e-03 | 158 | 47 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 6.42e-03 | 51 | 47 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 6.92e-03 | 53 | 47 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 7.44e-03 | 55 | 47 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 7.94e-03 | 1244 | 47 | 8 | GO:0000978 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 8.80e-03 | 60 | 47 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 8.99e-03 | 1271 | 47 | 8 | GO:0000987 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 9.69e-03 | 187 | 47 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 9.96e-03 | 64 | 47 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.06e-02 | 66 | 47 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.06e-02 | 66 | 47 | 2 | GO:0001098 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NFYA DAB2 CARM1 ONECUT2 BCL9L NCOA3 NCOA6 CHD6 PRPF6 CHD7 SFPQ ZMIZ1 SSBP4 BCL9 FOXA2 NKX2-1 CREBBP DICER1 MAML3 MEIS2 ARNT2 | 2.95e-13 | 1390 | 46 | 21 | GO:0045944 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 2.44e-06 | 276 | 46 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 5.61e-06 | 596 | 46 | 9 | GO:0001701 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 8.87e-06 | 336 | 46 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 1.01e-05 | 343 | 46 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 2.46e-05 | 906 | 46 | 10 | GO:0043009 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 3.04e-05 | 929 | 46 | 10 | GO:0009792 | |
| GeneOntologyBiologicalProcess | embryo development | DAB2 NCOA3 NCOA6 CHD7 ZMIZ1 FOXA2 CREBBP DICER1 CECR2 MEIS2 EPN2 ARNT2 | 5.26e-05 | 1437 | 46 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.37e-05 | 445 | 46 | 7 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 6.67e-05 | 192 | 46 | 5 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 7.18e-05 | 195 | 46 | 5 | GO:1903844 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 8.86e-05 | 482 | 46 | 7 | GO:0007178 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.02e-04 | 210 | 46 | 5 | GO:0007219 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.15e-04 | 347 | 46 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.23e-04 | 883 | 46 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | chromatin organization | 1.37e-04 | 896 | 46 | 9 | GO:0006325 | |
| GeneOntologyBiologicalProcess | head development | 1.66e-04 | 919 | 46 | 9 | GO:0060322 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 1.79e-04 | 237 | 46 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 1.98e-04 | 242 | 46 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition | 2.00e-04 | 130 | 46 | 4 | GO:0010717 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.08e-04 | 741 | 46 | 8 | GO:0006338 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.38e-04 | 136 | 46 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.92e-04 | 412 | 46 | 6 | GO:0090287 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 3.09e-04 | 999 | 46 | 9 | GO:0071824 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.92e-04 | 155 | 46 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 4.98e-04 | 296 | 46 | 5 | GO:0048762 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 5.22e-04 | 850 | 46 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | brain development | 5.60e-04 | 859 | 46 | 8 | GO:0007420 | |
| GeneOntologyCellularComponent | transcription regulator complex | NFYA CARM1 BCL9L NCOA3 NCOA6 SFPQ BCL9 FOXA2 NKX2-1 CREBBP ARNT2 | 6.33e-08 | 596 | 47 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | chromatin | NFYA ADNP2 ONECUT2 NCOA3 CHD6 CHD7 SFPQ ZMIZ1 ZFHX4 FOXA2 NKX2-1 CREBBP CECR2 MEIS2 ARNT2 ZBTB8B | 6.75e-08 | 1480 | 47 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | paraspeckles | 1.26e-06 | 10 | 47 | 3 | GO:0042382 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 2.36e-06 | 272 | 47 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NFYA CARM1 BCL9L NCOA3 NCOA6 PRPF6 SFPQ BCL9 CREBBP CPSF3 CECR2 HNRNPM | 3.83e-05 | 1377 | 47 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | membrane coat | 9.42e-05 | 106 | 47 | 4 | GO:0030117 | |
| GeneOntologyCellularComponent | coated membrane | 9.42e-05 | 106 | 47 | 4 | GO:0048475 | |
| GeneOntologyCellularComponent | clathrin coat | 2.72e-04 | 56 | 47 | 3 | GO:0030118 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.80e-04 | 13 | 47 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | fibrillar center | 4.15e-04 | 156 | 47 | 4 | GO:0001650 | |
| GeneOntologyCellularComponent | vesicle coat | 4.61e-04 | 67 | 47 | 3 | GO:0030120 | |
| GeneOntologyCellularComponent | coated vesicle membrane | 1.37e-03 | 215 | 47 | 4 | GO:0030662 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 3.30e-03 | 38 | 47 | 2 | GO:0030125 | |
| GeneOntologyCellularComponent | nuclear matrix | 3.84e-03 | 140 | 47 | 3 | GO:0016363 | |
| GeneOntologyCellularComponent | clathrin-coated vesicle membrane | 4.41e-03 | 147 | 47 | 3 | GO:0030665 | |
| MousePheno | abnormal prenatal body size | DAB2 CARM1 BCL9L NCOA3 NCOA6 IRS1 ZMIZ1 BCL9 FOXA2 NKX2-1 CREBBP DICER1 MEIS2 SEC23A | 2.48e-06 | 1116 | 42 | 14 | MP:0010866 |
| MousePheno | abnormal prenatal growth/weight/body size | DAB2 CARM1 BCL9L NCOA3 NCOA6 IRS1 CHD7 ZMIZ1 BCL9 FOXA2 NKX2-1 CREBBP DICER1 MEIS2 SEC23A | 1.50e-05 | 1493 | 42 | 15 | MP:0004196 |
| MousePheno | decreased embryo size | DAB2 CARM1 BCL9L NCOA3 NCOA6 ZMIZ1 FOXA2 CREBBP DICER1 SEC23A | 1.89e-05 | 659 | 42 | 10 | MP:0001698 |
| MousePheno | abnormal neurohypophysis morphology | 1.99e-05 | 18 | 42 | 3 | MP:0004164 | |
| MousePheno | decreased circulating glucagon level | 2.77e-05 | 20 | 42 | 3 | MP:0002696 | |
| MousePheno | abnormal primitive endoderm morphology | 4.89e-05 | 24 | 42 | 3 | MP:0011183 | |
| MousePheno | abnormal embryonic growth/weight/body size | DAB2 CARM1 BCL9L NCOA3 NCOA6 CHD7 ZMIZ1 BCL9 FOXA2 CREBBP DICER1 MEIS2 SEC23A | 6.87e-05 | 1295 | 42 | 13 | MP:0002088 |
| MousePheno | abnormal embryo size | DAB2 CARM1 BCL9L NCOA3 NCOA6 ZMIZ1 BCL9 FOXA2 CREBBP DICER1 SEC23A | 8.65e-05 | 956 | 42 | 11 | MP:0001697 |
| MousePheno | abnormal secretory circumventricular organ morphology | 8.73e-05 | 29 | 42 | 3 | MP:0013563 | |
| MousePheno | abnormal circumventricular organ morphology | 1.07e-04 | 31 | 42 | 3 | MP:0013562 | |
| MousePheno | increased carbon dioxide production | 1.98e-04 | 38 | 42 | 3 | MP:0008963 | |
| MousePheno | abnormal circulating glucagon level | 2.31e-04 | 40 | 42 | 3 | MP:0002695 | |
| MousePheno | decreased cell proliferation | 2.84e-04 | 739 | 42 | 9 | MP:0000352 | |
| MousePheno | abnormal hypothalamus morphology | 3.07e-04 | 44 | 42 | 3 | MP:0000837 | |
| Domain | BCL9_beta-catenin-bd_dom | 5.68e-06 | 2 | 45 | 2 | IPR024670 | |
| Domain | BCL9 | 5.68e-06 | 2 | 45 | 2 | PF11502 | |
| Domain | Bcl-9 | 5.68e-06 | 2 | 45 | 2 | IPR015668 | |
| Domain | NOPS | 1.70e-05 | 3 | 45 | 2 | PF08075 | |
| Domain | NOPS | 1.70e-05 | 3 | 45 | 2 | IPR012975 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | SM00592 | |
| Domain | BRK_domain | 8.46e-05 | 6 | 45 | 2 | IPR006576 | |
| Domain | Nuc_rcpt_coact | 8.46e-05 | 6 | 45 | 2 | IPR009110 | |
| Domain | ENTH | 8.46e-05 | 6 | 45 | 2 | PF01417 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | PF07533 | |
| Domain | ENTH | 2.02e-04 | 9 | 45 | 2 | PS50942 | |
| Domain | ENTH | 2.02e-04 | 9 | 45 | 2 | SM00273 | |
| Domain | HOMEOBOX_1 | 2.50e-04 | 236 | 45 | 5 | PS00027 | |
| Domain | ENTH | 2.52e-04 | 10 | 45 | 2 | IPR013809 | |
| Domain | HOX | 2.55e-04 | 237 | 45 | 5 | SM00389 | |
| Domain | Homeobox_dom | 2.65e-04 | 239 | 45 | 5 | IPR001356 | |
| Domain | HOMEOBOX_2 | 2.65e-04 | 239 | 45 | 5 | PS50071 | |
| Domain | Homeodomain-like | 1.17e-03 | 332 | 45 | 5 | IPR009057 | |
| Domain | Chromo_domain | 1.51e-03 | 24 | 45 | 2 | IPR023780 | |
| Domain | PAS | 1.64e-03 | 25 | 45 | 2 | PF00989 | |
| Domain | PAS_fold | 1.64e-03 | 25 | 45 | 2 | IPR013767 | |
| Domain | - | 1.78e-03 | 26 | 45 | 2 | 1.25.40.90 | |
| Domain | Chromo | 1.78e-03 | 26 | 45 | 2 | PF00385 | |
| Domain | Bromodomain_CS | 1.78e-03 | 26 | 45 | 2 | IPR018359 | |
| Domain | CHROMO_2 | 2.06e-03 | 28 | 45 | 2 | PS50013 | |
| Domain | CHROMO_1 | 2.06e-03 | 28 | 45 | 2 | PS00598 | |
| Domain | Helicase_C | 2.18e-03 | 107 | 45 | 3 | PF00271 | |
| Domain | HELICc | 2.18e-03 | 107 | 45 | 3 | SM00490 | |
| Domain | ENTH_VHS | 2.21e-03 | 29 | 45 | 2 | IPR008942 | |
| Domain | Helicase_C | 2.24e-03 | 108 | 45 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.30e-03 | 109 | 45 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.30e-03 | 109 | 45 | 3 | PS51192 | |
| Domain | DEXDc | 2.30e-03 | 109 | 45 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.36e-03 | 110 | 45 | 3 | IPR014001 | |
| Domain | Homeobox | 2.39e-03 | 234 | 45 | 4 | PF00046 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | PF00176 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | IPR000330 | |
| Domain | PAS | 2.69e-03 | 32 | 45 | 2 | SM00091 | |
| Domain | Chromodomain-like | 2.69e-03 | 32 | 45 | 2 | IPR016197 | |
| Domain | CHROMO | 2.86e-03 | 33 | 45 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 2.86e-03 | 33 | 45 | 2 | IPR000953 | |
| Domain | PAS | 3.03e-03 | 34 | 45 | 2 | IPR000014 | |
| Domain | PAS | 3.03e-03 | 34 | 45 | 2 | PS50112 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 3.21e-03 | 35 | 45 | 2 | IPR002464 | |
| Domain | BROMODOMAIN_1 | 3.58e-03 | 37 | 45 | 2 | PS00633 | |
| Domain | DEAH_ATP_HELICASE | 3.78e-03 | 38 | 45 | 2 | PS00690 | |
| Domain | Bromodomain | 3.78e-03 | 38 | 45 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.38e-03 | 41 | 45 | 2 | PS50014 | |
| Domain | BROMO | 4.60e-03 | 42 | 45 | 2 | SM00297 | |
| Domain | Bromodomain | 4.60e-03 | 42 | 45 | 2 | IPR001487 | |
| Domain | - | 4.60e-03 | 42 | 45 | 2 | 1.20.920.10 | |
| Domain | - | 4.72e-03 | 283 | 45 | 4 | 1.10.10.60 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.92e-07 | 55 | 34 | 5 | M27001 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 3.36e-07 | 118 | 34 | 6 | M27316 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 2.96e-06 | 42 | 34 | 4 | M27172 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 1.02e-05 | 18 | 34 | 3 | M26942 | |
| Pathway | WP_MRNA_PROCESSING | 1.19e-05 | 126 | 34 | 5 | M39406 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.91e-05 | 22 | 34 | 3 | MM1370 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.14e-05 | 154 | 34 | 5 | M27832 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.60e-05 | 27 | 34 | 3 | M26943 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 4.75e-05 | 84 | 34 | 4 | M1008 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 6.50e-05 | 91 | 34 | 4 | M39700 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 7.29e-05 | 34 | 34 | 3 | M39771 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.36e-04 | 110 | 34 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 1.38e-04 | 42 | 34 | 3 | M17541 | |
| Pathway | PID_HNF3A_PATHWAY | 1.59e-04 | 44 | 34 | 3 | M285 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.19e-04 | 49 | 34 | 3 | M41832 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.06e-04 | 11 | 34 | 2 | MM1521 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 3.09e-04 | 55 | 34 | 3 | M27145 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 3.67e-04 | 12 | 34 | 2 | M7968 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 3.72e-04 | 143 | 34 | 4 | M39591 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 3.99e-04 | 60 | 34 | 3 | M41830 | |
| Pathway | PID_AR_PATHWAY | 4.19e-04 | 61 | 34 | 3 | M58 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 5.05e-04 | 14 | 34 | 2 | M27808 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 5.81e-04 | 15 | 34 | 2 | M48323 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 6.28e-04 | 70 | 34 | 3 | M938 | |
| Pathway | WP_MRNA_PROCESSING | 6.51e-04 | 451 | 34 | 6 | MM15946 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 6.63e-04 | 16 | 34 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 6.63e-04 | 16 | 34 | 2 | M27940 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.04e-03 | 20 | 34 | 2 | M27881 | |
| Pathway | WP_FOXA2_PATHWAY | 1.15e-03 | 21 | 34 | 2 | M42579 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.27e-03 | 22 | 34 | 2 | MM1443 | |
| Pathway | REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES | 1.27e-03 | 22 | 34 | 2 | M46437 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.33e-03 | 201 | 34 | 4 | M39605 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.35e-03 | 91 | 34 | 3 | M27101 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 1.38e-03 | 23 | 34 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.51e-03 | 24 | 34 | 2 | M13404 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 1.57e-03 | 96 | 34 | 3 | M26973 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.64e-03 | 25 | 34 | 2 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.77e-03 | 26 | 34 | 2 | M2499 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.77e-03 | 26 | 34 | 2 | MM14793 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.89e-03 | 757 | 34 | 7 | M27451 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.05e-03 | 28 | 34 | 2 | M6177 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.35e-03 | 30 | 34 | 2 | M207 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 3.02e-03 | 34 | 34 | 2 | M46422 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 3.11e-03 | 122 | 34 | 3 | M29689 | |
| Pathway | REACTOME_GASTRULATION | 3.64e-03 | 129 | 34 | 3 | M46433 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CARM1 BCL9L NCOA3 NCOA6 SFPQ ZMIZ1 BCL9 FOXA2 PSPC1 CREBBP MAML3 HNRNPM | 7.91e-13 | 457 | 47 | 12 | 32344865 |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 11701890 | ||
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 15449938 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.22e-08 | 351 | 47 | 8 | 38297188 | |
| Pubmed | Role of nuclear receptor coactivator 3 (Ncoa3) in pluripotency maintenance. | 2.31e-08 | 5 | 47 | 3 | 22977234 | |
| Pubmed | NFYA BCL9L NCOA3 NCOA6 CHD6 CHD7 EIF3F ZMIZ1 SSBP4 BCL9 ZFHX4 SMAP2 CREBBP | 3.44e-08 | 1429 | 47 | 13 | 35140242 | |
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 4.61e-08 | 6 | 47 | 3 | 11076796 | |
| Pubmed | CARM1 FAM171A1 NCOA3 CHD7 SFPQ BCL9 NHSL2 ZC3H4 SEC23A ARHGAP44 HNRNPM | 4.85e-08 | 963 | 47 | 11 | 28671696 | |
| Pubmed | 5.84e-08 | 152 | 47 | 6 | 38360978 | ||
| Pubmed | 7.21e-08 | 268 | 47 | 7 | 33640491 | ||
| Pubmed | 8.06e-08 | 7 | 47 | 3 | 17043108 | ||
| Pubmed | 9.65e-08 | 425 | 47 | 8 | 24999758 | ||
| Pubmed | Rearrangement of the Protein Phosphatase 1 Interactome During Heart Failure Progression. | 1.30e-07 | 174 | 47 | 6 | 29669786 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ONECUT2 CHD6 PRPF6 CHD7 SFPQ EIF3F PSPC1 ZC3H4 CPSF3 CECR2 HNRNPM | 1.57e-07 | 1082 | 47 | 11 | 38697112 |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.59e-07 | 180 | 47 | 6 | 35198878 | |
| Pubmed | 2.04e-07 | 469 | 47 | 8 | 27634302 | ||
| Pubmed | 3.47e-07 | 43 | 47 | 4 | 26487511 | ||
| Pubmed | 5.05e-07 | 12 | 47 | 3 | 15383283 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.03e-06 | 398 | 47 | 7 | 35016035 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 1.28e-06 | 411 | 47 | 7 | 35182466 | |
| Pubmed | 1.55e-06 | 17 | 47 | 3 | 19183483 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28675294 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16938873 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 38811552 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15371335 | ||
| Pubmed | Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin. | 1.79e-06 | 2 | 47 | 2 | 21632823 | |
| Pubmed | Control of CBP co-activating activity by arginine methylation. | 1.79e-06 | 2 | 47 | 2 | 12374746 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29530979 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20682801 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 8758910 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 33767438 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21144806 | ||
| Pubmed | Expression and functional significance of mouse paraspeckle protein 1 on spermatogenesis. | 1.79e-06 | 2 | 47 | 2 | 15140795 | |
| Pubmed | 2.05e-06 | 638 | 47 | 8 | 33239621 | ||
| Pubmed | 2.44e-06 | 653 | 47 | 8 | 33742100 | ||
| Pubmed | 2.50e-06 | 655 | 47 | 8 | 35819319 | ||
| Pubmed | 2.59e-06 | 20 | 47 | 3 | 11877444 | ||
| Pubmed | 3.02e-06 | 21 | 47 | 3 | 19596656 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.03e-06 | 908 | 47 | 9 | 19274049 | |
| Pubmed | 3.87e-06 | 486 | 47 | 7 | 20936779 | ||
| Pubmed | 4.97e-06 | 83 | 47 | 4 | 28794006 | ||
| Pubmed | Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock. | 5.36e-06 | 3 | 47 | 2 | 14960326 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 18682709 | ||
| Pubmed | P54nrb forms a heterodimer with PSP1 that localizes to paraspeckles in an RNA-dependent manner. | 5.36e-06 | 3 | 47 | 2 | 16148043 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 34545187 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 33649334 | ||
| Pubmed | hnRNP M interacts with PSF and p54(nrb) and co-localizes within defined nuclear structures. | 5.36e-06 | 3 | 47 | 2 | 19874820 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16641145 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16467360 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 11713256 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 5.36e-06 | 3 | 47 | 2 | 11823864 | |
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 16254053 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 28533432 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 22859932 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 36595695 | ||
| Pubmed | 5.36e-06 | 3 | 47 | 2 | 20637214 | ||
| Pubmed | 7.19e-06 | 347 | 47 | 6 | 16033648 | ||
| Pubmed | 7.40e-06 | 1014 | 47 | 9 | 32416067 | ||
| Pubmed | 7.40e-06 | 28 | 47 | 3 | 24880616 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TIMM17B NCOA3 PRPF6 CLINT1 SMAP2 CREBBP DICER1 ARHGAP44 RTL9 EPN2 | 8.67e-06 | 1321 | 47 | 10 | 27173435 |
| Pubmed | 8.70e-06 | 206 | 47 | 5 | 22174317 | ||
| Pubmed | 8.76e-06 | 551 | 47 | 7 | 34728620 | ||
| Pubmed | Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors. | 9.15e-06 | 30 | 47 | 3 | 34017080 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 10551785 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 16227615 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 33589584 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 19699733 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 18347063 | ||
| Pubmed | LMX1B is part of a transcriptional complex with PSPC1 and PSF. | 1.07e-05 | 4 | 47 | 2 | 23308148 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 21914189 | ||
| Pubmed | CBP/p300 interact with and function as transcriptional coactivators of BRCA1. | 1.07e-05 | 4 | 47 | 2 | 10655477 | |
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 12509444 | ||
| Pubmed | 1.07e-05 | 4 | 47 | 2 | 26267537 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.20e-05 | 220 | 47 | 5 | 35785414 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.25e-05 | 582 | 47 | 7 | 20467437 | |
| Pubmed | 1.33e-05 | 225 | 47 | 5 | 12168954 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 1.36e-05 | 107 | 47 | 4 | 20508642 | |
| Pubmed | 1.38e-05 | 591 | 47 | 7 | 15231748 | ||
| Pubmed | 1.45e-05 | 1103 | 47 | 9 | 34189442 | ||
| Pubmed | 1.59e-05 | 1116 | 47 | 9 | 31753913 | ||
| Pubmed | ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer. | 1.78e-05 | 5 | 47 | 2 | 36114756 | |
| Pubmed | MGE-derived nNOS+ interneurons promote fear acquisition in nNOS-/- mice. | 1.78e-05 | 5 | 47 | 2 | 28974418 | |
| Pubmed | Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes. | 1.78e-05 | 5 | 47 | 2 | 18511550 | |
| Pubmed | Dynamic paraspeckle component localisation during spermatogenesis. | 1.78e-05 | 5 | 47 | 2 | 31299635 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 14766010 | ||
| Pubmed | The mitotic phosphorylation of p54(nrb) modulates its RNA binding activity. | 1.78e-05 | 5 | 47 | 2 | 21819346 | |
| Pubmed | LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction. | 1.78e-05 | 5 | 47 | 2 | 24360964 | |
| Pubmed | Transcription factor-specific requirements for coactivators and their acetyltransferase functions. | 1.78e-05 | 5 | 47 | 2 | 9445475 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 10381882 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 8813084 | ||
| Pubmed | TBX3 acts as tissue-specific component of the Wnt/β-catenin transcriptional complex. | 1.78e-05 | 5 | 47 | 2 | 32808927 | |
| Pubmed | Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models. | 1.78e-05 | 5 | 47 | 2 | 30760710 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 30475207 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 19598128 | ||
| Pubmed | Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives. | 1.78e-05 | 5 | 47 | 2 | 16806149 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 17052462 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 11912212 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 12810069 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 10224118 | ||
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 17220277 | ||
| Interaction | NUP35 interactions | BCL9L NCOA3 NCOA6 SFPQ ZMIZ1 BCL9 FOXA2 PSPC1 NKX2-1 CREBBP MAML3 HNRNPM | 1.73e-10 | 424 | 47 | 12 | int:NUP35 |
| Interaction | PAX7 interactions | 1.44e-08 | 124 | 47 | 7 | int:PAX7 | |
| Interaction | SOX7 interactions | 3.54e-08 | 82 | 47 | 6 | int:SOX7 | |
| Interaction | ERG interactions | 4.30e-08 | 223 | 47 | 8 | int:ERG | |
| Interaction | GSC interactions | 5.06e-08 | 87 | 47 | 6 | int:GSC | |
| Interaction | EWSR1 interactions | BCL9L NCOA3 NCOA6 PRPF6 CLINT1 SFPQ BCL9 PSPC1 CREBBP CECR2 SEC23A UBFD1 HNRNPM | 9.54e-08 | 906 | 47 | 13 | int:EWSR1 |
| Interaction | CRX interactions | 1.17e-07 | 254 | 47 | 8 | int:CRX | |
| Interaction | EGR2 interactions | 1.32e-07 | 171 | 47 | 7 | int:EGR2 | |
| Interaction | PAX8 interactions | 2.18e-07 | 111 | 47 | 6 | int:PAX8 | |
| Interaction | TBR1 interactions | 2.42e-07 | 113 | 47 | 6 | int:TBR1 | |
| Interaction | TBXT interactions | 2.83e-07 | 116 | 47 | 6 | int:TBXT | |
| Interaction | GATA2 interactions | 3.71e-07 | 199 | 47 | 7 | int:GATA2 | |
| Interaction | FEV interactions | 4.24e-07 | 203 | 47 | 7 | int:FEV | |
| Interaction | SP7 interactions | 4.61e-07 | 304 | 47 | 8 | int:SP7 | |
| Interaction | PYGO1 interactions | 5.10e-07 | 28 | 47 | 4 | int:PYGO1 | |
| Interaction | PAX9 interactions | 5.55e-07 | 130 | 47 | 6 | int:PAX9 | |
| Interaction | ETV4 interactions | 5.57e-07 | 69 | 47 | 5 | int:ETV4 | |
| Interaction | DTX2 interactions | 8.56e-07 | 330 | 47 | 8 | int:DTX2 | |
| Interaction | NCOA1 interactions | 1.10e-06 | 146 | 47 | 6 | int:NCOA1 | |
| Interaction | PAX6 interactions | 1.86e-06 | 366 | 47 | 8 | int:PAX6 | |
| Interaction | AR interactions | BCL9L NCOA3 NCOA6 PRPF6 CHD7 SFPQ ZMIZ1 BCL9 PSPC1 ZC3H4 CREBBP HNRNPM | 2.00e-06 | 992 | 47 | 12 | int:AR |
| Interaction | EP300 interactions | NFYA CARM1 NCOA3 NCOA6 PRPF6 CLINT1 SFPQ EIF3F SSBP4 PSPC1 ZC3H4 CREBBP CPSF3 HNRNPM | 2.23e-06 | 1401 | 47 | 14 | int:EP300 |
| Interaction | TLE3 interactions | 2.27e-06 | 376 | 47 | 8 | int:TLE3 | |
| Interaction | CPSF6 interactions | 2.96e-06 | 526 | 47 | 9 | int:CPSF6 | |
| Interaction | SOX9 interactions | 3.04e-06 | 97 | 47 | 5 | int:SOX9 | |
| Interaction | TLX1 interactions | 3.14e-06 | 175 | 47 | 6 | int:TLX1 | |
| Interaction | NKX2-1 interactions | 3.70e-06 | 180 | 47 | 6 | int:NKX2-1 | |
| Interaction | LHX1 interactions | 4.09e-06 | 103 | 47 | 5 | int:LHX1 | |
| Interaction | RBM14 interactions | 4.44e-06 | 553 | 47 | 9 | int:RBM14 | |
| Interaction | TLX3 interactions | 4.67e-06 | 291 | 47 | 7 | int:TLX3 | |
| Interaction | MECP2 interactions | ONECUT2 CHD6 PRPF6 CHD7 SFPQ EIF3F PSPC1 NKX2-1 ZC3H4 CPSF3 HECW2 CECR2 HNRNPM | 5.04e-06 | 1287 | 47 | 13 | int:MECP2 |
| Interaction | ORC6 interactions | 5.09e-06 | 49 | 47 | 4 | int:ORC6 | |
| Interaction | PARP1 interactions | NFYA CARM1 NCOA6 CHD6 PRPF6 CHD7 SFPQ PSPC1 NKX2-1 CREBBP CECR2 SEC23A EPN2 | 6.43e-06 | 1316 | 47 | 13 | int:PARP1 |
| Interaction | GTSE1 interactions | 1.02e-05 | 215 | 47 | 6 | int:GTSE1 | |
| Interaction | RARA interactions | 1.26e-05 | 223 | 47 | 6 | int:RARA | |
| Interaction | VSX1 interactions | 1.68e-05 | 66 | 47 | 4 | int:VSX1 | |
| Interaction | EED interactions | DAB2 CARM1 TIMM17B PRPF6 CHD7 CLINT1 SFPQ EIF3F PSPC1 CPSF3 SEC23A EPN2 HNRNPM | 1.76e-05 | 1445 | 47 | 13 | int:EED |
| Interaction | NCOA2 interactions | 1.89e-05 | 141 | 47 | 5 | int:NCOA2 | |
| Interaction | EYA4 interactions | 2.05e-05 | 243 | 47 | 6 | int:EYA4 | |
| Interaction | YWHAH interactions | FAM171A1 NCOA3 NCOA6 IRS1 PRPF6 CLINT1 SMAP2 NHSL2 CREBBP EPN2 UBFD1 | 3.51e-05 | 1102 | 47 | 11 | int:YWHAH |
| Interaction | PAX2 interactions | 4.58e-05 | 85 | 47 | 4 | int:PAX2 | |
| Interaction | FUS interactions | 5.37e-05 | 757 | 47 | 9 | int:FUS | |
| Interaction | TEAD1 interactions | 5.47e-05 | 176 | 47 | 5 | int:TEAD1 | |
| Interaction | FXR2 interactions | 5.77e-05 | 430 | 47 | 7 | int:FXR2 | |
| Interaction | MORC2 interactions | 5.98e-05 | 91 | 47 | 4 | int:MORC2 | |
| Interaction | FOXI1 interactions | 6.24e-05 | 92 | 47 | 4 | int:FOXI1 | |
| Interaction | LHX2 interactions | 6.58e-05 | 183 | 47 | 5 | int:LHX2 | |
| Interaction | LHX3 interactions | 6.93e-05 | 185 | 47 | 5 | int:LHX3 | |
| Interaction | SOX17 interactions | 7.08e-05 | 95 | 47 | 4 | int:SOX17 | |
| Interaction | GATA3 interactions | 7.29e-05 | 187 | 47 | 5 | int:GATA3 | |
| Interaction | SMAD3 interactions | 7.36e-05 | 447 | 47 | 7 | int:SMAD3 | |
| Interaction | SOX2 interactions | BCL9L NCOA3 NCOA6 CHD6 CHD7 CLINT1 EIF3F BCL9 ZFHX4 MEIS2 SEC23A HNRNPM | 7.48e-05 | 1422 | 47 | 12 | int:SOX2 |
| Interaction | HNF1B interactions | 7.86e-05 | 190 | 47 | 5 | int:HNF1B | |
| Interaction | CTNNB1 interactions | 9.02e-05 | 1009 | 47 | 10 | int:CTNNB1 | |
| Interaction | SMG7 interactions | 9.33e-05 | 319 | 47 | 6 | int:SMG7 | |
| Interaction | ARNT2 interactions | 9.33e-05 | 102 | 47 | 4 | int:ARNT2 | |
| Interaction | TADA2A interactions | 9.55e-05 | 198 | 47 | 5 | int:TADA2A | |
| Interaction | JUN interactions | 1.01e-04 | 470 | 47 | 7 | int:JUN | |
| Interaction | RUNX1 interactions | 1.02e-04 | 324 | 47 | 6 | int:RUNX1 | |
| Interaction | CEBPA interactions | NFYA NCOA3 NCOA6 PRPF6 CHD7 CLINT1 SFPQ BCL9 PSPC1 CREBBP HNRNPM | 1.06e-04 | 1245 | 47 | 11 | int:CEBPA |
| Interaction | SP100 interactions | 1.15e-04 | 206 | 47 | 5 | int:SP100 | |
| Interaction | TFF1 interactions | 1.19e-04 | 41 | 47 | 3 | int:TFF1 | |
| Interaction | ISL1 interactions | 1.19e-04 | 41 | 47 | 3 | int:ISL1 | |
| Interaction | ISL2 interactions | 1.19e-04 | 41 | 47 | 3 | int:ISL2 | |
| Interaction | NPAS2 interactions | 1.28e-04 | 42 | 47 | 3 | int:NPAS2 | |
| Interaction | TFAP2A interactions | 1.44e-04 | 114 | 47 | 4 | int:TFAP2A | |
| Interaction | EIF4E interactions | 1.60e-04 | 221 | 47 | 5 | int:EIF4E | |
| Interaction | SCARNA22 interactions | 1.64e-04 | 118 | 47 | 4 | int:SCARNA22 | |
| Interaction | SSBP3 interactions | 1.69e-04 | 119 | 47 | 4 | int:SSBP3 | |
| Interaction | NCOA3 interactions | 1.70e-04 | 224 | 47 | 5 | int:NCOA3 | |
| Interaction | RNF113A interactions | 1.78e-04 | 692 | 47 | 8 | int:RNF113A | |
| Interaction | WDR5 interactions | 1.85e-04 | 1101 | 47 | 10 | int:WDR5 | |
| Interaction | PPP1CA interactions | 1.86e-04 | 696 | 47 | 8 | int:PPP1CA | |
| Interaction | TOP1 interactions | 1.86e-04 | 696 | 47 | 8 | int:TOP1 | |
| Interaction | PYGO2 interactions | 1.91e-04 | 48 | 47 | 3 | int:PYGO2 | |
| Interaction | BCL9L interactions | 1.91e-04 | 48 | 47 | 3 | int:BCL9L | |
| Interaction | TP53BP1 interactions | 2.19e-04 | 533 | 47 | 7 | int:TP53BP1 | |
| Interaction | FMR1 interactions | 2.26e-04 | 536 | 47 | 7 | int:FMR1 | |
| Interaction | ONECUT1 interactions | 2.37e-04 | 10 | 47 | 2 | int:ONECUT1 | |
| Interaction | XRCC6 interactions | 2.52e-04 | 928 | 47 | 9 | int:XRCC6 | |
| Interaction | NONO interactions | 2.62e-04 | 549 | 47 | 7 | int:NONO | |
| Interaction | PRRC2A interactions | 2.74e-04 | 389 | 47 | 6 | int:PRRC2A | |
| Interaction | TBP interactions | 2.99e-04 | 253 | 47 | 5 | int:TBP | |
| Interaction | LDB2 interactions | 3.02e-04 | 56 | 47 | 3 | int:LDB2 | |
| Interaction | SRF interactions | 3.07e-04 | 139 | 47 | 4 | int:SRF | |
| Interaction | FURIN interactions | 3.10e-04 | 255 | 47 | 5 | int:FURIN | |
| Interaction | LHX6 interactions | 3.35e-04 | 58 | 47 | 3 | int:LHX6 | |
| Interaction | CTBP1 interactions | 3.44e-04 | 406 | 47 | 6 | int:CTBP1 | |
| Interaction | EPHA5 interactions | 3.51e-04 | 144 | 47 | 4 | int:EPHA5 | |
| Interaction | SSBP4 interactions | 3.53e-04 | 59 | 47 | 3 | int:SSBP4 | |
| Interaction | GATA4 interactions | 3.67e-04 | 411 | 47 | 6 | int:GATA4 | |
| Interaction | FBXW7 interactions | 4.08e-04 | 1215 | 47 | 10 | int:FBXW7 | |
| Interaction | HNF4A interactions | 4.38e-04 | 275 | 47 | 5 | int:HNF4A | |
| Interaction | CREBBP interactions | 4.43e-04 | 599 | 47 | 7 | int:CREBBP | |
| Interaction | PTP4A3 interactions | 4.53e-04 | 154 | 47 | 4 | int:PTP4A3 | |
| Interaction | LMO1 interactions | 4.53e-04 | 154 | 47 | 4 | int:LMO1 | |
| Interaction | DOT1L interactions | 5.02e-04 | 807 | 47 | 8 | int:DOT1L | |
| Interaction | YWHAG interactions | FAM171A1 NCOA6 IRS1 CLINT1 SMAP2 NHSL2 CPSF3 EPN2 UBFD1 HNRNPM | 5.05e-04 | 1248 | 47 | 10 | int:YWHAG |
| Interaction | BRCA1 interactions | NFYA CARM1 NCOA3 PRPF6 SFPQ ZMIZ1 CREBBP SEC23A MAP3K14 HNRNPM | 5.08e-04 | 1249 | 47 | 10 | int:BRCA1 |
| Interaction | LMO4 interactions | 5.11e-04 | 159 | 47 | 4 | int:LMO4 | |
| Cytoband | 20q12 | 2.79e-04 | 24 | 47 | 2 | 20q12 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.57e-04 | 15 | 29 | 2 | 529 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.33e-04 | 17 | 29 | 2 | 486 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.28e-04 | 25 | 29 | 2 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.25e-03 | 53 | 29 | 2 | 532 | |
| GeneFamily | RNA binding motif containing | 4.70e-03 | 213 | 29 | 3 | 725 | |
| GeneFamily | Basic helix-loop-helix proteins | 1.34e-02 | 110 | 29 | 2 | 420 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FAM171A1 NCOA3 IRS1 CLINT1 ZMIZ1 ZC3H4 CREBBP DICER1 MEIS2 ARNT2 MAP3K14 | 2.51e-07 | 856 | 47 | 11 | M4500 |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 7.94e-07 | 289 | 47 | 7 | M13630 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.64e-06 | 467 | 47 | 8 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.13e-06 | 484 | 47 | 8 | MM999 | |
| Coexpression | SCHEIDEREIT_IKK_INTERACTING_PROTEINS | 2.49e-06 | 53 | 47 | 4 | M6303 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 1.38e-05 | 294 | 47 | 6 | M40873 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.55e-05 | 300 | 47 | 6 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.83e-05 | 466 | 47 | 7 | M13522 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 2.46e-05 | 94 | 47 | 4 | M18108 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP | 2.71e-05 | 197 | 47 | 5 | M4211 | |
| Coexpression | GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP | 2.91e-05 | 200 | 47 | 5 | M9447 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | 6.53e-05 | 1009 | 47 | 9 | M157 | |
| Coexpression | NUTT_GBM_VS_AO_GLIOMA_DN | 7.77e-05 | 46 | 47 | 3 | M2577 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | 9.62e-05 | 822 | 47 | 8 | M6782 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 9.73e-05 | 258 | 47 | 5 | M2446 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 1.22e-04 | 271 | 47 | 5 | MM1075 | |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 2.29e-04 | 167 | 47 | 4 | M8857 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.73e-06 | 331 | 47 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | 1.18e-05 | 837 | 47 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 4.49e-05 | 978 | 47 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 5.56e-05 | 186 | 47 | 5 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 6.35e-05 | 815 | 47 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | 9.69e-05 | 492 | 47 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.61e-04 | 406 | 47 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.62e-04 | 259 | 47 | 5 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.86e-04 | 413 | 47 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-05 | 165 | 47 | 4 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-05 | 165 | 47 | 4 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.16e-05 | 171 | 47 | 4 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-05 | 178 | 47 | 4 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-05 | 178 | 47 | 4 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.70e-05 | 178 | 47 | 4 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-05 | 178 | 47 | 4 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.70e-05 | 178 | 47 | 4 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.86e-05 | 180 | 47 | 4 | c3d1521ac90f2e3fc31158e6e61907e05c37af39 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.03e-05 | 182 | 47 | 4 | a95956ce4adccb34cc0c47ebfa1878ce4617904e | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-05 | 182 | 47 | 4 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.03e-05 | 182 | 47 | 4 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.12e-05 | 183 | 47 | 4 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.12e-05 | 183 | 47 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 184 | 47 | 4 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.21e-05 | 184 | 47 | 4 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 185 | 47 | 4 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 185 | 47 | 4 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.30e-05 | 185 | 47 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.30e-05 | 185 | 47 | 4 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.48e-05 | 187 | 47 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 188 | 47 | 4 | 6164d467b612767ceba15de34176bcc8e8c36ab8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-05 | 188 | 47 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.67e-05 | 189 | 47 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 5.17e-05 | 194 | 47 | 4 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 195 | 47 | 4 | ef2304acb01638df197f42dcc3db8c5867f4dc17 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.27e-05 | 195 | 47 | 4 | 5ed495941b80221206b8a9a86d92221ab8ba6682 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 195 | 47 | 4 | 12ba6d95e42d06b1991b011043c0e3370a7b4131 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.49e-05 | 197 | 47 | 4 | 47c4d9de71a435119c71f5219de836cf9b2aab6d | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 200 | 47 | 4 | ed941933457f8bf63b277025286ef0485e78f4d0 | |
| ToppCell | 5'-GW_trimst-1|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.82e-05 | 200 | 47 | 4 | a4c6d0cccba7aee35eaedf29faff32b9494b6582 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Npw|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.31e-04 | 113 | 47 | 3 | 165de4316059222f33d1e51aeff4554037c0b937 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.51e-04 | 142 | 47 | 3 | d08e1880425d285c4433014fe0242ac7ff7734af | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.09e-04 | 148 | 47 | 3 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 5.60e-04 | 153 | 47 | 3 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.93e-04 | 156 | 47 | 3 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.93e-04 | 156 | 47 | 3 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.93e-04 | 156 | 47 | 3 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-FB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.27e-04 | 159 | 47 | 3 | b4bc888e978b1b577721b891b0af6ba9a1607044 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 6.27e-04 | 159 | 47 | 3 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 6.50e-04 | 161 | 47 | 3 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.50e-04 | 161 | 47 | 3 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-04 | 162 | 47 | 3 | 0ccdb224ee3c585a6d0caffde5608d9d3cc452f8 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-04 | 162 | 47 | 3 | 9ccee8e7e78e16b0149a94867e12d86d3b04f9b9 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.61e-04 | 162 | 47 | 3 | 0d35752a7249b3c62b8007ec8a775c37d16b8d31 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 6.61e-04 | 162 | 47 | 3 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.73e-04 | 163 | 47 | 3 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.10e-04 | 166 | 47 | 3 | 9fd9de82f98b9acdaa59ac98fb9664161514aec0 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 7.10e-04 | 166 | 47 | 3 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-04 | 168 | 47 | 3 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 7.35e-04 | 168 | 47 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.48e-04 | 169 | 47 | 3 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.61e-04 | 170 | 47 | 3 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Uncommitted_AE_cell|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.61e-04 | 170 | 47 | 3 | 5a64e05c263df915085988d881808221e2c0f2e2 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.74e-04 | 171 | 47 | 3 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 7.87e-04 | 172 | 47 | 3 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-04 | 172 | 47 | 3 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor | 8.00e-04 | 173 | 47 | 3 | dba09ba9748871e38a16449d500ae4d7b405c42f | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 174 | 47 | 3 | 75b3a852140fb726025c3c987143d67944afde2d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 174 | 47 | 3 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-04 | 175 | 47 | 3 | c9dc6aa652ac887470806a950311657c423d9495 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 8.27e-04 | 175 | 47 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.41e-04 | 176 | 47 | 3 | 212e643c50c68462d4b016428ab30eeb7868ef40 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.41e-04 | 176 | 47 | 3 | 62870115e31170c8b42eec57c709e0fe32388b37 | |
| ToppCell | normal_Lung-Endothelial_cells-EPCs|normal_Lung / Location, Cell class and cell subclass | 8.41e-04 | 176 | 47 | 3 | 71d1bd425772d89d8c550b909e0ec0e36ff22a7e | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 8.55e-04 | 177 | 47 | 3 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.55e-04 | 177 | 47 | 3 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 8.55e-04 | 177 | 47 | 3 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 8.69e-04 | 178 | 47 | 3 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | 0f5cf34609df791c8baebfdc6590f6eb4dbe0509 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | d9eba884e18a0c89bdc70c194bfe4d62cca164fa | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | b03aa1de9d20895ebad55f6fcd6fe7a49335db5a | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | 88dbec952507d84b85b08165eec80df99ed1e736 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | daf8189a22786171e2b629261cf720736aa4ebdb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.83e-04 | 179 | 47 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.97e-04 | 180 | 47 | 3 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | cadb18fc73031eb9f779599e15cd7861337fee78 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 9.12e-04 | 181 | 47 | 3 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.12e-04 | 181 | 47 | 3 | 6771f2c72073c59aab905945a619907b7fd0fd77 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | 85bec4d3f255f4c61c790325eeb50ad38f709ef2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.12e-04 | 181 | 47 | 3 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | dc55de945c6f78f32eb3a1b3520835eb8417e068 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.26e-04 | 182 | 47 | 3 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | c1e0be27064e14043b78ae501b02d4e9542267a3 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.26e-04 | 182 | 47 | 3 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-04 | 182 | 47 | 3 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.26e-04 | 182 | 47 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.26e-04 | 182 | 47 | 3 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 8.27e-08 | 180 | 47 | 7 | 4541_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.32e-06 | 170 | 47 | 6 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.41e-06 | 172 | 47 | 6 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.90e-06 | 181 | 47 | 6 | 6951_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.96e-06 | 182 | 47 | 6 | 3887_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 2.09e-06 | 184 | 47 | 6 | 6939_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 2.16e-06 | 185 | 47 | 6 | 1114_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.68e-05 | 171 | 47 | 5 | 7535_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.91e-05 | 174 | 47 | 5 | 1659_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.99e-05 | 175 | 47 | 5 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.08e-05 | 176 | 47 | 5 | 7499_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.16e-05 | 177 | 47 | 5 | 1645_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.16e-05 | 177 | 47 | 5 | 6434_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.25e-05 | 178 | 47 | 5 | 1112_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.80e-05 | 184 | 47 | 5 | 2321_DN | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 188 | 47 | 5 | 3291_DN | |
| Drug | Glucose | DAB2 TIMM17B IRS1 PRPF6 CHD7 CLINT1 SFPQ FOXA2 CREBBP EPN2 UBFD1 | 1.16e-04 | 1420 | 47 | 11 | ctd:D005947 |
| Drug | fluorosilicate | 1.16e-04 | 8 | 47 | 2 | CID000028117 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 4.75e-05 | 7 | 45 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 3.29e-04 | 616 | 45 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.29e-04 | 616 | 45 | 6 | C0376358 | |
| Disease | C-reactive protein measurement | 4.26e-04 | 1206 | 45 | 8 | EFO_0004458 | |
| Disease | vital capacity | 5.02e-04 | 1236 | 45 | 8 | EFO_0004312 | |
| Disease | granulocyte count | 6.05e-04 | 254 | 45 | 4 | EFO_0007987 | |
| Disease | testosterone measurement | 6.16e-04 | 1275 | 45 | 8 | EFO_0004908 | |
| Disease | Kallmann Syndrome | 7.22e-04 | 26 | 45 | 2 | C0162809 | |
| Disease | monocyte percentage of leukocytes | 8.10e-04 | 731 | 45 | 6 | EFO_0007989 | |
| Disease | Hyperinsulinism | 8.38e-04 | 28 | 45 | 2 | C0020459 | |
| Disease | age at menopause | 1.15e-03 | 302 | 45 | 4 | EFO_0004704 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.62e-03 | 152 | 45 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Diaphragmatic Hernia | 1.80e-03 | 41 | 45 | 2 | C0019284 | |
| Disease | Carcinoma, Transitional Cell | 1.80e-03 | 41 | 45 | 2 | C0007138 | |
| Disease | Congenital Heart Defects | 2.07e-03 | 44 | 45 | 2 | C0018798 | |
| Disease | pneumonia | 2.35e-03 | 47 | 45 | 2 | EFO_0003106 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GPSVVMASPGMMQSG | 321 | Q9UKF6 | |
| MGSVPGMAISPSRMP | 756 | Q92793 | |
| MAGLQLMTPASSPMG | 11 | Q9UPY3 | |
| MADPGMMSLFGEDGN | 1 | Q9P2D1 | |
| RGVQGGDSMMDSPEM | 891 | Q9BXF3 | |
| SGAAAPMAGSMPGMP | 646 | Q6IQ32 | |
| PMAATGQVRMAGAMP | 26 | Q9HBZ2 | |
| PASGMNMSGMGGLGS | 131 | P43699 | |
| NPAVMMGAEGMEGGA | 161 | Q9P2P5 | |
| FNQSPSMAPGAMMGG | 521 | P98082 | |
| SMAPGAMMGGQPSGF | 526 | P98082 | |
| MMSPGGEGDLHTPML | 401 | Q5VUB5 | |
| GGPMPMSMPNVMTGT | 546 | Q14677 | |
| VMTGTMGMAPLGNTP | 556 | Q14677 | |
| MVMSGLSQGVPGMPA | 1046 | Q96JK9 | |
| GSSLTPLGPAMMNMV | 606 | O95208 | |
| MMNMVGSVGIPPSAA | 616 | O95208 | |
| SMPGDYVSQGGPMGM | 386 | O14770 | |
| GLSMERMVPAGMGAG | 526 | P52272 | |
| MGGPAISMASPMSIP | 586 | Q86X55 | |
| EMDTPGEMLMTGRGS | 341 | Q32MK0 | |
| MSMSCDSSPPGMGMS | 131 | O95948 | |
| RVDPNGYMMMSPSGG | 656 | P35568 | |
| TVMIPPGGNVSSSMM | 181 | Q14686 | |
| MGVPGRTMGVMFTPL | 221 | O00303 | |
| MLPGMAAVPQMFGVG | 2521 | Q8TD26 | |
| PGPGFSHMQGMMGEQ | 1266 | O00512 | |
| QMAGGEGLAGTPMGM | 726 | Q86UU0 | |
| SMMMAPGGPDSLNAP | 1201 | Q86UU0 | |
| TTMQGMEQAMPGAGP | 21 | Q96JQ5 | |
| VNSGGMVMMVPGAGS | 231 | P23511 | |
| MAVMEMACPGAPGSA | 1 | Q99558 | |
| SLAGMSPGAGAMAGM | 76 | Q9Y261 | |
| GVMSPGMMTIPDFGT | 136 | Q8NET4 | |
| MSTPLMGAPASGNMS | 411 | Q8NET4 | |
| QPMSTQDPGGMSMSP | 721 | Q8NET4 | |
| GPNPPGMESMGMVYS | 361 | Q5HYW2 | |
| MTPGLMTPGTGELDM | 226 | O94906 | |
| ENPTAGGAAVMRPMM | 1196 | Q9Y6Q9 | |
| TEAPMLDGMSPGESM | 756 | Q17R89 | |
| IMMFIGGPATQGPGM | 286 | Q15436 | |
| PGVPPATMSGSMMGS | 646 | P23246 | |
| LPGSATFGMPGMTGM | 1711 | Q86UP3 | |
| TFGMPGMTGMAGSLL | 1716 | Q86UP3 | |
| SDLVMGLPGMAQMGT | 306 | Q7RTX0 | |
| MAAAGAPDGMEEPGM | 1 | O14562 | |
| VAQPGASGMVAPMAM | 321 | Q8WU79 | |
| ASGMVAPMAMPAGYM | 326 | Q8WU79 | |
| PAMGPEGAANMGTPM | 441 | Q8WXF1 | |
| EGAANMGTPMMPDNG | 446 | Q8WXF1 | |
| MGTPMMPDNGAVHND | 451 | Q8WXF1 | |
| PVMGSMAPGDTMAAG | 101 | Q9BWG4 | |
| MAPGDTMAAGSMAAG | 106 | Q9BWG4 | |
| RSGPLAMVGSAMMGG | 106 | O60830 | |
| MMPYGPGDSPHSGMM | 671 | Q9UPT8 | |
| MSGMMTNAIGGPAAG | 241 | Q96EQ0 | |
| MAAGMTPSGMSGPPM | 351 | Q9ULJ6 | |
| GRPEGAGVAMSSMMD | 306 | Q8NAP8 |